Veterinary Medicines

Cardisure Flavoured 1.25 mg Tablets for Dogs

Authorised
  • Pimobendan
Download as PDF

Product identification

Medicine name:
Cardisure Flavoured 1.25 mg Tablets for Dogs
Cardisure 1.25 mg Tablet
Cardisure 1.25 mg Comprimé
Cardisure 1.25 mg Tablette
Active substance:
  • Pimobendan
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pimobendan
    1.25
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC01CE90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • 10 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
  • 10 blisters per carton, 10 tablets per blister (Aluminium - Aluminium blister)
  • 2 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
  • 2 blisters per carton, 10 tablets per blister (Aluminium - Aluminium blister)
  • 25 blisters per carton, 10 tablets per blister (Aluminium - Aluminium blister)
  • 25 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
  • 5 blisters per carton, 10 tablets per blister (Aluminium - PVC,PE,PVDC blister)
  • 5 blisters per carton, 10 tablets per blister (Aluminium - Aluminium blister)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • DALES PHARMACEUTICALS LIMITED
  • Eurovet Animal Health B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0280/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 16/06/2022
Download
Dutch (PDF)
Published on: 23/01/2023
Download
French (PDF)
Published on: 23/01/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/03/2023
Download
French (PDF)
Published on: 6/03/2023
Download
German (PDF)
Published on: 6/03/2023
Download

107727 PAR.pdf

English (PDF)
Published on: 16/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."